ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 146 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $160,759 | -64.1% | 6,602 | -50.1% | 0.00% | -100.0% |
| Q1 2024 | $447,182 | -78.2% | 13,242 | -79.6% | 0.00% | -75.0% |
| Q4 2023 | $2,048,189 | -48.4% | 64,960 | -58.2% | 0.00% | -60.0% |
| Q3 2023 | $3,971,901 | +66.2% | 155,456 | +86.6% | 0.01% | +11.1% |
| Q2 2023 | $2,389,417 | +1092.5% | 83,313 | +605.2% | 0.01% | +800.0% |
| Q4 2022 | $200,365 | -49.0% | 11,814 | +1.7% | 0.00% | -75.0% |
| Q2 2021 | $393,000 | -21.4% | 11,620 | -4.0% | 0.00% | -50.0% |
| Q1 2021 | $500,000 | +31.2% | 12,106 | -56.9% | 0.01% | -50.0% |
| Q1 2020 | $381,000 | -48.2% | 28,057 | -58.6% | 0.02% | -30.4% |
| Q4 2019 | $736,000 | – | 67,702 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Portolan Capital Management | 484,907 | $11,807,485 | 0.97% |
| Nikko Asset Management Americas, Inc. | 1,563,065 | $37,966,849 | 0.44% |
| Diametric Capital, LP | 32,765 | $797,827 | 0.43% |
| ARK Investment Management | 1,964,964 | $47,846,871 | 0.42% |
| SummerHaven Investment Management, LLC | 23,400 | $569,790 | 0.38% |
| Quantedge Capital Pte Ltd | 40,800 | $993,480 | 0.36% |
| Granahan Investment Management | 344,549 | $8,389,768 | 0.34% |
| FEDERATED HERMES, INC. | 4,694,060 | $114,300,361 | 0.27% |
| Belmont Capital, LLC | 40,000 | $974,000 | 0.18% |
| Woodline Partners LP | 754,023 | $18,360,460 | 0.18% |